• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAbSci
    Picture of AbSci logo

    ABSI — AbSci Share News

    $8.450.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    • Market Cap
      $1.46bn
    • Enterprise Value
      $1.28bn
    • Revenue
      $2.80m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • Discussion
    • ABSI Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    Discussion
    ABSI Dividends
    • Drug developer Absci slides after $50 million stock offering

      25/07/2025 12:03
    • Brief: Absci Prices Public Offering At $3.00 Per Share

      25/07/2025 01:48
    • Brief: ABSCI Announces Proposed Public Offering Of Common Stock

      24/07/2025 23:37
    • Brief: Absci Corp Files For Common Stock Offering Of Up To $50 Million - SEC Filing

      24/07/2025 23:33
    • Absci Corp reports results for the quarter ended March 31 - Earnings Summary

      13/05/2025 22:02
    • Brief: Absci Q1 Revenue USD 1.179 Million

      13/05/2025 21:05
    • Brief: Absci Announces First Participants Dosed In Phase 1 Clinical Trial Of Abs-101, A Potential Best-In-Class Anti-TL1a Antibody For The Treatment Of Inflammatory Bowel Disease

      13/05/2025 21:02
    • Absci Corp expected to post a loss of 23 cents a share - Earnings Preview

      10/05/2025 24:07
    • U.S. STOCKS ON THE MOVE-Wells Fargo, American Express, Mondelez

      11/04/2025 19:29
    • U.S. STOCKS ON THE MOVE-TreeHouse Foods, Sarepta Therapeutics, Walmart

      11/04/2025 16:50
    • U.S. STOCKS ON THE MOVE-Morgan Stanley, Fluence Energy, Bank of New York

      11/04/2025 14:16
    • AI-based drug developers rise on US FDA's plans to replace animal testing

      11/04/2025 12:54
    • Brief: Absci Corp Files Prospectus To Offer & Resale, From Time To Time, Of Up To 5.7 Million Shares Of Common Stock By Selling Stockholder - SEC Filing

      01/04/2025 21:35
    • Absci Corp reports results for the quarter ended December 31 - Earnings Summary

      18/03/2025 21:01
    • Absci Corp expected to post a loss of 24 cents a share - Earnings Preview

      14/03/2025 20:36
    • Brief: Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

      04/03/2025 22:06
    • U.S. STOCKS ON THE MOVE-SmartFinancial, TE Connectivity, Arista Networks

      22/01/2025 18:41
    • U.S. STOCKS ON THE MOVE-MP Materials, Seagate, Teledyne

      22/01/2025 15:41
    • U.S. STOCKS ON THE MOVE-Interactive Brokers, Travelers, LanzaTech

      22/01/2025 14:06
    • U.S. STOCKS ON THE MOVE-Johnson & Johnson, United Airlines, AI stocks

      22/01/2025 12:09
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.